Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
نویسندگان
چکیده
BACKGROUND Statins are effective in preventing cardiovascular events, but patients do not fully adhere to them. OBJECTIVE To determine whether patients are more adherent to generic statins versus brand-name statins (lovastatin, pravastatin, or simvastatin) and whether greater adherence improves health outcomes. DESIGN Observational, propensity score-matched, new-user cohort study. SETTING Linked electronic data from medical and pharmacy claims. PARTICIPANTS Medicare beneficiaries aged 65 years or older with prescription drug coverage between 2006 and 2008. INTERVENTION Initiation of a generic or brand-name statin. MEASUREMENTS Adherence to statin therapy (measured as the proportion of days covered [PDC] up to 1 year) and a composite outcome comprising hospitalization for an acute coronary syndrome or stroke and all-cause mortality. Hazard ratios (HRs) and absolute rate differences were estimated. RESULTS A total of 90,111 patients who initiated a statin during the study was identified; 83,731 (93%) initiated a generic drug, and 6380 (7%) initiated a brand-name drug. The mean age of patients was 75.6 years, and most (61%) were female. The average PDC was 77% for patients in the generic group and 71% for those in the brand-name group (P<0.001). An 8% reduction in the rate of the clinical outcome was observed among patients in the generic group versus those in the brand-name group (HR, 0.92 [95% CI, 0.86 to 0.99]). The absolute difference was -1.53 events per 100 person-years (CI, -2.69 to -0.19 events per 100 person-years). LIMITATION Results may not be generalizable to other populations with different incomes or drug benefit structures. CONCLUSION Compared with those initiating brand-name statins, patients initiating generic statins were more likely to adhere and had a lower rate of a composite clinical outcome. PRIMARY FUNDING SOURCE Teva Pharmaceuticals.
منابع مشابه
Summaries for patients. Comparative effectiveness of generic and brand-name statins on patient outcomes.
متن کامل
Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
OBJECTIVE To explore adherence/persistence with generic gabapentin/venlafaxine versus brand-name gabapentin/venlafaxine (Neurontin(®)/Vandral(®)) in peripheral neuropathic pain (pNP) or generalized anxiety disorder (GAD), respectively, and whether it is translated into different costs and patient outcomes in routine medical practice. METHODS A retrospective, new-user cohort study was designed...
متن کاملStatin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
BACKGROUND Generic statins may be considered as a compelling treatment option for managing dyslipidemia, due to their reduced cost, compared to their brand name equivalent. However, further assessment is needed to determine whether using a particular generic statin is more cost-effective relative to other brand-name statins. OBJECTIVE The purpose of this study is to compare the cost-effective...
متن کاملComparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome
BACKGROUND Although generic medications are approved based on bioequivalence with brand-name medications, there remains substantial concern regarding their clinical effectiveness and safety. Lipitor(®), available as generic atorvastatin, is one of the most commonly prescribed statins. Therefore, we compared the effectiveness of generic atorvastatin products and Lipitor(®). METHODS AND RESULTS...
متن کاملThe impact of manufacturer coupon use in the statin market.
BACKGROUND Pharmaceutical manufacturer coupons are a rapidly growing promotional activity intended to encourage initiation and continuing use of brand-name medications, but little is known about impacts on medication adherence and expenditures. OBJECTIVE To understand which patients use manufacturer coupons and the impact of coupons on brand-name statin (atorvastatin and rosuvastatin) use and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of internal medicine
دوره 161 6 شماره
صفحات -
تاریخ انتشار 2014